Pure Global AI
NCT06265805Recruiting

Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients

A Randomized Controlled Trial to Explore the Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients
Zeng ChanghaoClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
comprehensive rehabilitation therapy
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Zeng Changhao
Funder
People's Hospital of Zhengzhou University
Location
Xinzhu, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Feb 28, 2024
End date
Dec 30, 2024
Enrollment
80 participants
Primary outcome

Generalized Anxiety Disorder 7

Summary

The goal of this clinical trial is to compare the differences on Psychological Condition and
 Experience in ischemic stroke patients using Intermittent Oro-esophageal Tube and Nasogastric
 Tube. Patients will be randomly divided into an observation group and a control group, all
 receiving routine rehabilitation treatment. On this basis, the observation group will use
 Intermittent Oro esophageal Tube for enteral nutrition support, while the control group will
 use Nasogastric Tube. Researchers will compare Psychological Condition and Experience of two
 groups.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06265805
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06265805 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Recruiting. The study focuses on Ischemic Stroke. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.